Meneses G. Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19. IMC J Med Sci [Internet]. 2021 Apr. 5 [cited 2024 Nov. 21];14(2):67-8. Available from: https://banglajol.info/index.php/IMCJMS/article/view/52833